GPT and Jeune syndrome: A recent systematic review and meta-analysis reported normalization of ALT, AST, ALP, bilirubin, and GGT levels in 83%, 87%, 53%, 50%, and 70% of patients, respectively, following ATD treatment [2]. Although many clinicians monitor liver function during ATD therapy, evidence for its effectiveness in detecting early liver injury is limited.